skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Vectura and Philip Morris: the leopard has not changed its spots

Thorax, 2022-06, Vol.77 (6), p.537-538 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0040-6376 ;EISSN: 1468-3296 ;DOI: 10.1136/thoraxjnl-2021-218328 ;PMID: 34949723

Full text available

Citations Cited by
  • Title:
    Vectura and Philip Morris: the leopard has not changed its spots
  • Author: Hopkinson, Nicholas S
  • Subjects: Animals ; Asthma ; Cigarettes ; Corporate profits ; Editorial ; Funding ; Humans ; Inhalers ; Lung diseases ; Market shares ; Panthera ; Profitability ; Public policy ; Smoking ; tobacco control ; Tobacco Industry
  • Is Part Of: Thorax, 2022-06, Vol.77 (6), p.537-538
  • Description: The idea that a company which, based on its market share and the global death toll, kills more than a million people every year4 should be allowed to expand into the delivery of healthcare has been widely condemned, including by the British Thoracic Society (BTS) (box 1), the European Respiratory Society5 and the US COPD Foundation, as well as the American Lung Association and American Thoracic Society who referred to the move as ‘reprehensible’.6Box 1 British Thoracic Society Statement on Philip Morris International’s takeover of Vectura Vectura, a company that for over 20 years has worked to treat lung disease, is now part of the tobacco industry. Article 5.3 of the WHO Framework Convention on Tobacco Control also proscribes tobacco industry influence on public policy. Fortunately, as outlined in detail elsewhere,4 there are numerous alternatives available, so avoiding initiation of these devices or switching away from them should be straightforward for most people, and has a sound ethical basis in beneficence, non-maleficence, autonomy and distributive justice.4 It is important to stress that any adjustment to an individual’s inhaled medication must include ensuring that they understand the reason for the switch and have the appropriate support to ensure that they are able to use the device in question. Tobacco companies currently evade accountability for huge external costs they generate including ill health, lost productivity and environmental degradation.1–3 The global societal aggregated costs of smoking are calculated to be $2.1 trillion dollars, 2.9% of global GDP.9 Given its market share, rather than expanding into new areas, PMI should instead be being held liable for around $240 billion/year of this.
  • Publisher: England: BMJ Publishing Group Ltd and British Thoracic Society
  • Language: English
  • Identifier: ISSN: 0040-6376
    EISSN: 1468-3296
    DOI: 10.1136/thoraxjnl-2021-218328
    PMID: 34949723
  • Source: AUTh Library subscriptions: ProQuest Central
    MEDLINE
Back to results list
Go to Previous pagePrevious Result  3 NextGo to Next page
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait